id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3422700,77ac9618-c136-4ba6-ba3e-7eb4d50f6dbc,3T,"THE CONAFAY GROUP, LLC",401004840,LIFESCIENCE LOGISTICS,2025,third_quarter,MED,Medical countermeasure and supply management.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2025-08-01T17:12:18-04:00
3425687,79dfb569-2ed5-4ae9-a814-13f3ee9c9d2a,3T,GABBERT CONSULTING CO LLC,401105309,"CHIPPS, CAFFREY AND DUBILIER, P. S. C.",2025,third_quarter,MED,Lobbyed against medicaid cuts in the Big Beautiful Bill Met with VA to discuss benefits of outsourcing Pathology,"HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",9000,,0,1,2025-09-16T14:25:33-04:00
3426240,27275696-3bad-43c7-9c9c-0c605e596b2f,Q3,HYDROCEPHALUS ASSOCIATION,401109608,HYDROCEPHALUS ASSOCIATION,2025,third_quarter,MED,"H.R. 5304 / S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - maintain or increase funding for the NIH","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2025-09-26T09:55:33-04:00
3426432,086abe74-f210-4408-b65d-0fc758d192b1,Q3,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2025,third_quarter,MED,Monitor health data budgets and policy.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-09-30T16:58:34-04:00
3426514,3157a475-ffdf-4422-8ce9-88a6a5e6d75c,Q3,"AUBURN HEALTH STRATEGIES, LLC",292697,AMERICAN PROFICIENCY INSTITUTE,2025,third_quarter,MED,proficiency testing for clinical laboratories,,,,0,0,2025-10-01T09:53:47-04:00
3426602,cbe0eed0-c43b-4b6f-b8f5-074b80196774,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,HAZELDEN BETTY FORD FOUNDATION,2025,third_quarter,MED,Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-01T12:23:12-04:00
3426650,e773778f-a2dc-4737-8e5a-afb3007f7205,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,CHILDREN'S NATIONAL MEDICAL CENTER,2025,third_quarter,MED,"Health-related issues including reimbursement, research, public-health & clinical care.","Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2025-10-01T13:49:58-04:00
3426656,667c7892-8861-421e-b958-cace50beb982,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,CITY OF HOPE MEDICAL CENTER,2025,third_quarter,MED,Issues related to Medicare/Medicaid reimbursement and clinical research.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-01T13:51:12-04:00
3426699,732ebc99-6dd3-42ea-ae00-be0aaa88918d,Q3,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2025,third_quarter,MED,"USDA ARS Human Nutrition Research funding in FY2025 Full-Year Continuing Appropriations and Extensions Act, P.L. 119-4, and FY2026 Agriculture Appropriations","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-10-01T14:38:35-04:00
3426776,b14f3ab4-d44f-4c38-a142-3b548c682baa,Q3,SQUIRE PATTON BOGGS,30906,ALLIANCE FOR BIOSECURITY,2025,third_quarter,MED,Preparedness and response as it relates to Biosecurity.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",80000,,0,0,2025-10-01T16:08:22-04:00
3426981,a08b6061-a76e-45b0-8ef0-b5c7cc9fb455,Q3,SQUIRE PATTON BOGGS,30906,"LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.",2025,third_quarter,MED,Funding support for federally qualified health centers; reauthorization of programs,,20000,,0,0,2025-10-02T11:44:39-04:00
3427046,10dacbc9-2e3b-4de7-9201-a09b94c0764b,3A,"FRANCIS EDWARD & CRONIN, INC.",311314,LEWY BODY DEMENTIA ASSOCIATION,2025,third_quarter,MED,Legislation related to Alzheimer's disease and related dementias research.,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2025-10-02T12:49:49-04:00
3427074,3b07bfbb-345d-44ae-8077-3133735a1a56,Q3,"MAGILL ASSOCIATES, LLC",401103511,THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES,2025,third_quarter,MED,FY 2026 appropriations for the development of a synthetic vaccine,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2025-10-02T14:26:22-04:00
3427090,373ad73b-d370-4ed0-bbb6-dd424b5357c6,Q3,THE HARRIS FIRM,68376,HOLISTIC INDUSTRIES INC.,2025,third_quarter,MED,Issues pertaining to cannabis CSA scheduling.,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",50000,,0,0,2025-10-02T14:59:44-04:00
3427715,e46989bb-e3b2-4013-8a75-9bc2ae5fdee4,Q3,OCAL LOBBYING GROUP,401106825,SAMERA S.A.,2025,third_quarter,MED,Planning for year end project initiative,,,,0,0,2025-10-05T17:19:35-04:00
3427716,946f3971-fd1e-4579-8848-6cf95621c57e,Q3,OCAL LOBBYING GROUP,401106825,BR.MANNESMAN TECHNOLOGY,2025,third_quarter,MED,TB Research,,,,0,0,2025-10-05T17:22:25-04:00
3427994,51496706-2448-402d-b669-d882ae716745,Q3,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2025,third_quarter,MED,Labor/HHS/Education Appropriations: Provisions relating to disease research,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-06T13:42:55-04:00
3428013,269b9c23-56f0-47d9-bda3-6c9f3f57ead1,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PONCE HEALTH SCIENCES UNIVERSITY,2025,third_quarter,MED,Requesting HUD approval to restart construction on new dental clinic for Ponce Health Sciences University.,"Housing & Urban Development, Dept of (HUD)",20000,,0,0,2025-10-06T13:51:59-04:00
3428020,8e9bb02f-59e5-450e-b2d3-6526601fc225,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE UNIVERSITY OF TEXAS SYSTEM,2025,third_quarter,MED,"Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities.","HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2025-10-06T13:56:17-04:00
3428027,a374caed-69cd-4bb9-83c6-12840d7ecf67,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,DEFENSE HEALTH RESEARCH CONSORTIUM,2025,third_quarter,MED,"HR 4016/S 2572, FY26 Defense Appropriations Act, Defense Health Research Programs; HR 3906, Medical Research For Our Troops Act","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-06T13:57:01-04:00
3428038,a5675ddf-d304-45f6-87ef-9210441c4c04,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,PANCREATIC CANCER ACTION NETWORK (PANCAN),2025,third_quarter,MED,"HR 4016/S 2572, FY26 Defense Appropriations Act, Pancreatic Cancer Research Program; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH research on pancreatic cancer","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-06T14:03:57-04:00
3428042,86becfe6-e394-4461-9540-aa53e26bc32a,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,FOUNDATION FOR PERIPHERAL NEUROPATHY,2025,third_quarter,MED,"HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for peripheral neuropathy; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH research on peripheral neuropathy","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2025-10-06T14:06:08-04:00
3428047,5ef2d000-a184-4154-91ae-107a4cef3c0a,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2025,third_quarter,MED,"HR 4016/S 2572, FY26 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-06T14:10:21-04:00
3428054,de25bdb3-5771-4975-ac93-5a02296deaed,3T,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,KIDNEYCAN,2025,third_quarter,MED,"HR 5304/S 2587, FY26 Labor HHS Education Act, kidney cancer research at NIH","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,1,2025-10-06T14:11:52-04:00
3428055,68d2d104-7de3-46af-aa1a-0bce42c37322,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,VHL ALLIANCE,2025,third_quarter,MED,"HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Prgoram designation for VHL; HR 5304/ S 2587, FY26 Labor HHS Education Appropriations Act, NIH research on Von Hippel-Lindau syndrome","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-10-06T14:14:59-04:00
3428115,5cd37fa5-14c7-432a-ba3b-52e00a93bccf,Q3,CAPSTONE NATIONAL PARTNERS,8214,ATTERX BIOTHERAPEUTICS,2025,third_quarter,MED,FY26 Appropriations,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2025-10-06T14:45:24-04:00
3428158,fa667fbd-e85b-4833-ab90-b7b082c0a0d7,Q3,PRIMACY STRATEGY GROUP,401105877,ESSENTIA HEALTH,2025,third_quarter,MED,"Prior Authorization Simplification - H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act Establish an electronic prior authorization process for MA plans including a standardization for transactions and clinical attachments. Increase transparency around MA prior authorization requirements and its use. Clarify CMS authority to establish timeframes for e-PA requests including expedited determinations, real-time decisions for routinely approved items and services, and other PA requests. Expand beneficiary protections to improve enrollee experiences and outcomes. Require HHS and other agencies to report to Congress on program integrity efforts and other ways to further improve the e-PA process.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2025-10-06T15:07:32-04:00
3428277,d95239d5-5640-417c-9cc9-fb2b608b23d6,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2025,third_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2025-10-06T18:11:07-04:00
3428338,8d94c4e9-1fc3-408a-98ca-d1e5d9354d7f,Q3,"EFB ADVOCACY, LLC",401104430,ASSOCIATION OF AMERICAN CANCER INSTITUTES,2025,third_quarter,MED,Issues related to biomedical research National Institutes of Health appropriations funding,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",22500,,0,0,2025-10-07T09:45:59-04:00
3428354,92d0162c-8644-442b-b26e-245910981124,Q3,"EFB ADVOCACY, LLC",401104430,UNITED FOR MEDICAL RESEARCH,2025,third_quarter,MED,Funding Issues related to the National Institutes of Health,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-07T09:49:49-04:00
3428696,d2a111e0-8eef-4743-b2b1-e99065463171,Q3,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",401103161,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",2025,third_quarter,MED,NONE,,,10000,0,0,2025-10-07T15:31:55-04:00
3428829,ec383e2c-13fb-4301-a949-6e9fff317814,Q3,ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION),2241,ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION),2025,third_quarter,MED,Nutrition Research,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,75000,0,0,2025-10-07T23:03:59-04:00
3429165,8ef74dde-1320-4fe9-bc7e-8fc11e5fb8cb,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,MMV MEDICINES FOR MALARIA VENTURE,2025,third_quarter,MED,The purpose was to increase funding for malaria research in the Department of Defense.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-08T14:22:08-04:00
3429195,b45acd32-83a6-4bf8-87c9-37e0ce3f1580,Q3,MCDERMOTT+ LLC,401103287,VERILY LIFE SCIENCES LLC,2025,third_quarter,MED,"Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-10-08T14:37:01-04:00
3429665,daeb7c2a-506b-4d16-b0f1-456ea70a74ff,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE UNIVERSITY OF TEXAS AT SAN ANTONIO,2025,third_quarter,MED,Identify federal funding opportunities and partnerships with federal agencies.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-09T11:58:49-04:00
3430149,c7614d38-c2db-441e-b3e2-2287020ae5b7,Q3,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2025,third_quarter,MED,"vaccines, 340B, cdc reform, nih reform, pediatric research, NIH budget","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,34890,0,0,2025-10-10T14:41:19-04:00
3430251,0f77a8d8-3960-4a6d-a3b3-416397c4252a,3T,FORBES-TATE,400976792,CSL BEHRING,2025,third_quarter,MED,Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,1,2025-10-10T17:25:11-04:00
3430611,e2660a85-35db-47f5-804f-ff5fc2dd2148,Q3,TODD STRATEGY GROUP,401103321,VAXART INC.,2025,third_quarter,MED,Vaccine policy.,"Health & Human Services, Dept of (HHS)",50000,,0,0,2025-10-12T16:22:29-04:00
3430798,f0292284-d0e7-4a23-a463-77c35dc2ba86,Q3,NATURAL STATE CONSULTING AND STRATEGIES,401108145,TURBARE MANUFACTURING,2025,third_quarter,MED,S1407 ABC Safe Drug Act - Pro,SENATE,20000,,0,0,2025-10-13T09:42:54-04:00
3430816,aec381b1-455c-48aa-a47c-7692e2a63c05,Q3,"TERRAPOWER, LLC",401109474,"TERRAPOWER, LLC",2025,third_quarter,MED,"Implementation of H.R. 3684, Infrastructure Investment and Jobs Act (IIJA); Implementation of H.R 5376 - Inflation Reduction Act of 2022; Implementation of S. 870 - Fire Grants and Safety Act of 2023; Implementation of H.R.1042 - Prohibiting Russian Uranium Imports Act; Implementation of H.R. 1 - One Big Beautiful Act; FY26 Appropriations.","Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE",,160000,0,0,2025-10-13T09:51:08-04:00
3431420,5b373316-9ea7-4d88-8a42-23e1aa45807c,Q3,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2025,third_quarter,MED,Increased funding for pediatric medical research,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2025-10-13T18:22:29-04:00
3431433,b4ef69f5-57d3-4736-89f0-0f615c32f9bc,3T,TOWER 19,401105158,PEDIATRIC NEURO-ONCOLOGY CONSORTIUM FOUNDATION,2025,third_quarter,MED,Issues related to funding for pediatric cancer research.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2025-10-13T18:35:37-04:00
3431580,4f7195b3-fda2-4872-b2fb-eaac2d94c592,Q3,MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP),24486,"OSTEAL THERAPEUTICS, INC.",2025,third_quarter,MED,General federal government relations,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-14T09:53:45-04:00
3431967,253b9c8d-2b97-4d65-a754-191bf5a8e447,Q3,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,"INTUITIVE SURGICAL, INC.",2025,third_quarter,MED,Lobbying related to health care issues.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-10-14T12:47:01-04:00
3432036,24203cd4-4b7b-4f4d-a549-c5bb9c214bd3,Q3,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2025,third_quarter,MED,"Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2025-10-14T13:26:54-04:00
3432375,cb806710-47a5-4268-bf66-7acfd0431f6c,Q3,BEN BARNES GROUP LP,5415,HUNTSMAN CORPORATION,2025,third_quarter,MED,CMS Medicare,,10000,,0,0,2025-10-14T15:18:47-04:00
3432499,6d0ac188-c367-4caf-91ef-d1d401458d87,Q3,"THE LIVINGSTON GROUP, LLC",49635,INNOVATIVE VACCINE TECHNOLOGIES,2025,third_quarter,MED,FY2026 appropriations for the development of a synthetic vaccine,,,,0,0,2025-10-14T15:51:17-04:00
3432555,15f02b9a-7e8d-4e95-a13d-8011f47be1e2,Q3,VENABLE LLP,39941,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2025,third_quarter,MED,"State Department reauthorization H. Res. 708, recognizing Medical Research Week",HOUSE OF REPRESENTATIVES,40000,,0,0,2025-10-14T16:09:47-04:00
3432671,cbd7af7d-b22d-4149-972c-2affa65895f2,Q3,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2025,third_quarter,MED,"Antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance, FDA proposed regulations regarding laboratory developed tests, House Energy and Commerce NIH RFI, Administration Executive Orders regarding HHS, NIH, HRSA, FDA, and CDC.","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,300000,0,0,2025-10-14T16:50:07-04:00
3432796,308c64fa-6cd1-48fd-9ed4-4c9273bb8b83,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,AMERICAN SOCIETY FOR RADIATION ONCOLOGY,2025,third_quarter,MED,Discussions regarding patient access to radiation oncology.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES",50000,,0,0,2025-10-14T19:05:34-04:00
3432977,e38ec1e9-72ac-4a88-991b-fa115bd3d895,Q3,ALPINE ADVISORS,401106595,"COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION",2025,third_quarter,MED,Issues pertaining to government-wide federal regulation of cannabis,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-14T23:23:03-04:00
3433073,a186ca63-7577-4ad9-8e4b-01ea36ffba44,Q3,TEAM HALLAHAN LLC,401104228,THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION),2025,third_quarter,MED,"Research and development efforts and FY 26 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2025-10-15T08:31:11-04:00
3433385,62aa200e-4a92-4901-bf38-6691e0e023d2,Q3,IMPACT MANAGEMENT GROUP,401104137,ARKANSAS RESEARCH ALLIANCE,2025,third_quarter,MED,On behalf of client support continued and future funding for clinical research programs in Arkansas,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2025-10-15T10:11:17-04:00
3433394,9a70de2b-c1e1-4e58-b62e-b9413464cc1c,Q3,BALLARD PARTNERS,401104288,BIOSTAR MEDICAL LLC,2025,third_quarter,MED,Promoting the advancement of healthcare technology.,,300000,,0,0,2025-10-15T10:12:21-04:00
3433405,a6b3d1ba-ca7d-4baa-ac1d-507c982c9529,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"ADVANCED MATERIALS AND DEVICES, INC.",2025,third_quarter,MED,Educated key government stakeholders on AMADs products applicable to the military and supported appropriations requests.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-10-15T10:16:51-04:00
3433416,9b671fd8-0839-4cb2-a1f0-40f23f544e02,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM,2025,third_quarter,MED,Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-10-15T10:19:12-04:00
3433422,2d460d2d-73bc-430f-b2c9-c8ee0e759ea7,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"MEDIVIEW XR, INC.",2025,third_quarter,MED,Educated government stakeholders on Mediviews technology and capabilities in support of clinical training and graduate medical education.,"Defense, Dept of (DOD)",30000,,0,0,2025-10-15T10:24:02-04:00
3433425,1cddc513-d059-4ccb-af94-c512524f230c,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"NIRSENSE, LLC (FKA BIONICA LABS)",2025,third_quarter,MED,Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations and authorization requests.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-15T10:25:58-04:00
3433462,5a99d8c3-e8f2-4d5f-b792-fe64198364d1,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,SMITH & NEPHEW,2025,third_quarter,MED,Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2025-10-15T10:34:04-04:00
3433478,d3061d31-422c-4879-ae15-af7af5944a4a,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,TELEFLEX INCORPORATED,2025,third_quarter,MED,Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.,"Defense, Dept of (DOD)",20000,,0,0,2025-10-15T10:36:00-04:00
3433495,bede7e75-67d9-4776-874b-8f786c3e6955,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE GENEVA FOUNDATION,2025,third_quarter,MED,Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2025-10-15T10:40:54-04:00
3433502,5cb28e65-db0e-42fd-9cfb-fe3a2f9f1d94,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ,2025,third_quarter,MED,Educated key government stakeholders on the University's medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-15T10:42:17-04:00
3433515,0b1efa52-8833-4bb6-bd9b-829c54d0a662,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,WASHINGTON STATE UNIVERSITY,2025,third_quarter,MED,Educated key government stakeholders on WSUs research and development activities in support of US Service members; support Defense appropriations.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-15T10:43:34-04:00
3433612,39d601a1-00da-4f17-8b87-43fe02e60a7d,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"GINKGO BIOWORKS, INC.",2025,third_quarter,MED,"Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, and biomanufacturing; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education.","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-10-15T11:10:32-04:00
3433628,35ad3c8f-bd42-4457-b9eb-73beb1efc2fd,Q3,"THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION",319118,"THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION",2025,third_quarter,MED,indirect cost allocations for federal grants Medicaid,"HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2025-10-15T11:16:13-04:00
3433992,79161c20-23fd-4de9-9ccc-c1e9af6671d1,Q3,THE UNIVERSITY OF TEXAS SYSTEM,39531,THE UNIVERSITY OF TEXAS SYSTEM,2025,third_quarter,MED,Funding related to medical research,"HOUSE OF REPRESENTATIVES,SENATE",,110000,0,0,2025-10-15T12:46:37-04:00
3434364,a61624f2-b645-49d5-a42e-b372bc2fdcc7,Q3,IPOLICY SOLUTIONS,401105127,ASSOCIATION FOR MOLECULAR PATHOLOGY,2025,third_quarter,MED,No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests,"HOUSE OF REPRESENTATIVES,SENATE",70500,,0,0,2025-10-15T14:08:00-04:00
3434423,359307d6-6e71-4dfe-bb18-a77d823f28b5,Q3,IPOLICY SOLUTIONS,401105127,ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION,2025,third_quarter,MED,Medical research workforce issues Facility and Administrative Costs,"HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2025-10-15T14:24:18-04:00
3434479,ba5a1e6f-6056-44f4-a64e-676800d53c21,3A,TEAM HALLAHAN LLC,401104228,THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION),2025,third_quarter,MED,"Research and development efforts and FY 26 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center.",SENATE,,,0,0,2025-10-15T14:44:25-04:00
3434586,a48c52fc-d7fa-4ee5-abc0-84c11e631f7f,Q3,CAPITOL COUNSEL LLC,313715,"ALNYLAM PHARMACEUTICALS, INC.",2025,third_quarter,MED,Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development.,Food & Drug Administration (FDA),30000,,0,0,2025-10-15T15:19:15-04:00
3434741,7e6736b0-a2e0-4068-b521-75a55ef1bdd2,Q3,CAPITOL COUNSEL LLC,313715,"TEMPUS LABS, INC.",2025,third_quarter,MED,"Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-10-15T15:54:40-04:00
3434795,76960347-b46b-4127-aab2-b71d2da837bf,Q3,IMPACT MANAGEMENT GROUP,401104137,"CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC.",2025,third_quarter,MED,On behalf of Client support continued and future funding for CARTI in Arkansas,HOUSE OF REPRESENTATIVES,,,0,0,2025-10-15T16:07:36-04:00
3434817,4e531c1c-d60a-460a-9d0f-50ac20320b65,Q3,BALLARD PARTNERS,401104288,EXTHERA MEDICAL CORPORATION,2025,third_quarter,MED,Guidance and advocacy related to procurement approval from the VA and DoD health systems.,"Health & Human Services, Dept of (HHS)",60000,,0,0,2025-10-15T16:12:55-04:00
3434857,2060743b-410f-4a19-b847-f6dbe195f292,Q3,NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH,26557,NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH,2025,third_quarter,MED,Need for continued biomedical research with animal models,"HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2025-10-15T16:22:20-04:00
3435279,56e83410-440f-42f2-9b9b-03d5c0d0ed76,Q3,BALLARD PARTNERS,401104288,"INSIGHTEC, INC.",2025,third_quarter,MED,Guidance on legislation and regulations regarding medical devices; advocacy regarding the use of medical devices at the VA.,"Veterans Affairs, Dept of (VA)",90000,,0,0,2025-10-15T20:27:38-04:00
3435360,ae1f5ec2-3a6e-45eb-b017-c66a728b9fd8,Q3,"W STRATEGIES, LLC",400605842,ALVEO TECHNOLOGIES,2025,third_quarter,MED,"Education related to diagnostic testing, especially as it relates to bird flu.",HOUSE OF REPRESENTATIVES,,,0,0,2025-10-15T22:32:23-04:00
3435551,06ac0f5f-825b-4acd-b742-6b8f30ed36be,Q3,AMERICAN PHYSICAL THERAPY ASSOCIATION,3093,AMERICAN PHYSICAL THERAPY ASSOCIATION,2025,third_quarter,MED,"NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,318889,0,0,2025-10-16T09:01:55-04:00
3435610,9622ba82-72ec-47a3-a9ff-58162a06aed1,Q3,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2025,third_quarter,MED,Policies with regard to indirect cost reimbursement rates at NIH,"HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2025-10-16T09:33:45-04:00
3435781,cd67c160-e3c1-41d9-ac72-6ca6566c57ae,Q3,TRAVERE THERAPEUTICS,401104190,TRAVERE THERAPEUTICS,2025,third_quarter,MED,"HR 1262, S 932 Give Kids a Chance Act to renew PRV program; related provisions in H.R.1, One Big Beautiful Bill Act; HR 4709, the Newborn Screening Reauthorization Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,110000,0,0,2025-10-16T10:12:56-04:00
3435949,7effdcef-145a-4e95-abdc-50fd106a8671,Q3,CURE SMA,401104586,CURE SMA,2025,third_quarter,MED,"medical research in spinal muscular atrophy, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, Medical Research for Our Troops Act (H.R. 3906)","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,75000,0,0,2025-10-16T10:40:59-04:00
3436076,b0fa756d-051d-4756-9103-b2a85d73582d,Q3,"MANATT, PHELPS, AND PHILLIPS",23645,LOMA LINDA UNIVERSITY MEDICAL CENTER,2025,third_quarter,MED,"Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF",,140000,,0,0,2025-10-16T11:01:00-04:00
3436090,f06ce687-852f-4061-8ba5-07b0b6b7380f,Q3,"MANATT, PHELPS, AND PHILLIPS",23645,MEDISYS HEALTH NETWORK,2025,third_quarter,MED,Provider Relief and COVID funding and other healthcare issues; Community Project Funding,,40000,,0,0,2025-10-16T11:02:05-04:00
3436159,8f1a0fc4-c870-4d4d-bd47-497e1715b24b,Q3,NELSON MULLINS RILEY & SCARBOROUGH,285871,"ANBEX, INC.",2025,third_quarter,MED,Stockpile potassium iodide to counteract effects of nuclear radiation.,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2025-10-16T11:15:01-04:00
3436297,e5e46092-e023-4051-9439-71eb78faa6e1,Q3,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2025,third_quarter,MED,No bill number: Urge NIH to continue funding for therapy research,Natl Institutes of Health (NIH),,189000,0,0,2025-10-16T11:37:11-04:00
3436316,3d953e09-70dc-4584-af97-d3d50e5f5cd9,Q3,CAPITOL COUNSEL LLC,313715,BOEHRINGER INGELHEIM ANIMAL HEALTH US,2025,third_quarter,MED,Issues regarding FDA animal drug approval process.,"Food & Drug Administration (FDA),SENATE",50000,,0,0,2025-10-16T11:40:31-04:00
3436480,9dd06d72-8dcb-4596-8c2c-48a0809ae3db,Q3,THE JACKSON LABORATORY,401104723,THE JACKSON LABORATORY,2025,third_quarter,MED,Issues related to biomedical research. Animal model use in biomedical research. Issues related to indirect cost reimbursement,"HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE",,30000,0,0,2025-10-16T12:07:46-04:00
3436523,6341644f-b094-414d-8b9f-ebf2658a740e,Q3,TROUTMAN STATEGIES,81511,MURAL HEALTH,2025,third_quarter,MED,"Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2025-10-16T12:28:03-04:00
3436673,02aff9b9-7ab4-4df3-983a-eb5978c10e7f,3A,TEAM HALLAHAN LLC,401104228,THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION),2025,third_quarter,MED,"Research and development efforts and FY 26 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2025-10-16T13:07:47-04:00
3437119,8e9602e5-c659-48a6-a751-e6f7e89c84d0,Q3,BALLARD PARTNERS,401104288,LIFESCIENCE LOGISTICS,2025,third_quarter,MED,Government stockpile storage.,"Health & Human Services, Dept of (HHS)",60000,,0,0,2025-10-16T14:17:18-04:00
3437430,9c32169d-6401-463f-acf7-a6541d96693f,Q3,"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.",52925,"HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.",2025,third_quarter,MED,"HR 2319/S 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health.","HOUSE OF REPRESENTATIVES,SENATE",,60000,0,0,2025-10-16T14:56:06-04:00
3437610,14496365-495c-49b5-b703-dca4d0f53a33,Q3,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,"OCTAPHARMA USA, INC.",2025,third_quarter,MED,Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.,"Defense, Dept of (DOD),SENATE",50000,,0,0,2025-10-16T15:19:21-04:00
3437656,ee400fb3-892f-4fd2-bfe9-cd91d3747121,Q3,ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE),400364697,ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE),2025,third_quarter,MED,Relief from clinical lab reductions in PAMA.,,,81111,0,0,2025-10-16T15:26:39-04:00
3437860,2d8e4aa6-c091-4140-840f-cac6855c34b8,Q3,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,32065,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,2025,third_quarter,MED,NIH facilities and administrative costs,"HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2025-10-16T16:00:47-04:00
3437870,1b0c6c54-b6de-459e-aa7c-a8caa10b71dc,Q3,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,32065,UNIVERSITY OF PITTSBURGH MEDICAL CENTER,2025,third_quarter,MED,NIH facilities and administrative costs,"HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2025-10-16T16:02:47-04:00
3437879,5a95da86-278d-4622-9e9c-337b46e5ec4a,Q3,DLA PIPER LLP (US),76855,ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED),2025,third_quarter,MED,Legislative and regulatory proposals and policies regarding medical device innovation.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-10-16T16:05:48-04:00
3438016,b06aa48c-4220-4401-b6cb-95f10234db6e,Q3,DLA PIPER LLP (US),76855,BIOTECHNOLOGY INNOVATION ORGANIZATION,2025,third_quarter,MED,"Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-10-16T16:24:37-04:00
3438756,3157b763-0dfe-425a-9c98-d506d39db81e,Q3,BALLARD PARTNERS,401104288,"NOVAVAX, INC.",2025,third_quarter,MED,Guidance navigating vaccine policy.,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE,White House Office",50000,,0,0,2025-10-16T22:10:37-04:00
3438794,5130df34-8f3d-4822-aabf-b78d0eec0ad6,Q3,COVINGTON & BURLING LLP,11195,RWE ALLIANCE INC.,2025,third_quarter,MED,Real-world health data and analytics policy.,Food & Drug Administration (FDA),80000,,0,0,2025-10-16T23:31:13-04:00
3438824,4305fa31-2c50-4c5a-a889-5f7e8265dee5,Q3,VAN SCOYOC ASSOCIATES,39837,COALITION OF EPSCOR STATES,2025,third_quarter,MED,"H.R.5304/S.2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026, IDeA program; and Indirect costs; and NIH Indirect costs IDeA program, generally S.2005, IDeA Reauthorization Act of 2025, Entirety",SENATE,150000,,0,0,2025-10-17T06:55:03-04:00
3438860,9c86ae0a-f508-482c-8849-37f1dde7db26,Q3,VAN SCOYOC ASSOCIATES,39837,"ARUP LABORATORIES, INC.",2025,third_quarter,MED,"FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Possible Reconciliation, FY2026, Health related provisions Possible Health policy package Monitor the following: Prescription drug costs, generally VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-10-17T07:36:48-04:00